Pathways
D-Alanine Metabolism in B. licheniformis DSM13
Description:
Bacillus licheniformis(B. licheniformis) is a Gram-positive, spore-forming soil bacterium that is used in the biotechnology industry to manufacture enzymes, antibiotics, biochemicals and consumer products. B. licheniformis, B. subtilis, and B. pumilus comprise the subtilis group, which has been associated with a range of clinical conditions, food spoilage such as ropy bread, and incidents of food-borne gastroenteritis. B. licheniformis has also been associated with septicemia, peri...
References:
-
Genomic Analysis of Bacillus licheniformis CBA7126 Isolated from a Human Fecal Sample.
Front Pharmacol. 2017 Oct 13;8:724. doi: 10.3389/fphar.2017.00724. -
Biosynthesis of the wall teichoic acid in Bacillus licheniformis.
Biochem J. 1972 Mar;127(1):27-37. doi: 10.1042/bj1270027. -
Lipid intermediates in the biosynthesis of bacterial peptidoglycan.
Microbiol Mol Biol Rev. 2007 Dec;71(4):620-35. doi: 10.1128/MMBR.00016-07. -
Inhibitors of alanine racemase enzyme: a review.
J Enzyme Inhib Med Chem. 2016 Aug;31(4):517-26. doi: 10.3109/14756366.2015.1050010. Epub 2015 May 29. Erratum in: J Enzyme Inhib Med Chem. 2018 Dec;33(1):726.
You can view details of this pathway by subscribing:
9853 Pacific Heights Blvd.
Suite D., San Diego, CA 92121, USA
Tel: 858-224-2869
Fax: 858-205-1192
info@proteinlounge.com
Databases
Tools
Institutional License
Need our databases and tools to be availed by your whole university or institute? We recommend signing up for our Site License.
To set up a license, please contact: info@proteinlounge.com
Copyright © Protein Lounge Inc.
Terms & Conditions